Smith Kline Beecham Clinical - Bakersfield, California 93301

Smith Kline Beecham Clinical is categorized under Medical Labs in Bakersfield, CA .

Business Name: Smith Kline Beecham Clinical
Address: 2920 H St, Bakersfield, California 93301
Phone Number: (661) 631-0687
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Labs
SIC Code: 8071
NAICS Code: 621511
Share This Business:
Related Businesses: Quest Diagnostics - Bakersfield, CA 93301
United Westlab Inc - Bakersfield, CA 93301
Laboratory Corporation Of America - Bakersfield, CA 93301
Kern Medical Center - Bakersfield, CA 93301
Unilab Corporation - Bakersfield, CA 93301
Physician's Automated Laboratory Inc - Bakersfield, CA 93301
Physicians Automated Lab Inc - Bakersfield, CA 93301
Same Day Std Testing - Bakersfield, CA 93301
Exam One - Bakersfield, CA 93301
Quest Diagnostics Incorporated - Bakersfield, CA 93301
Fertility Medical Center - Bakersfield, CA 93301
Central Valley Pulmonary Diagnostics - Bakersfield, CA 93301
Sonya M Kelly Phd - Bakersfield, CA 93301
Laboratory Corporation Of America - Bakersfield, CA 93301
Quest Diagnostics - Bakersfield, CA 93301
Test Me DNA Bakersfield - Bakersfield, CA 93301

The company Smith Kline Beecham Clinical provides B2C services in the form of Medical Labs from its single location in California. 1 to 4 employees work for Smith Kline Beecham Clinical, and the business now earns $100.000 to $499.999 per annum.

Smith Kline Beecham Clinical was launched in 2010 and is classified under SIC code and category 8071 , and NAICS number and grouping 621511 . To contact Smith Kline Beecham Clinical, please call with the phone number (661) 631-0687 or visit its single location at 2920 H St in Bakersfield, California 93301.

The location of the single location can also be found using the coordinates . Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.